Literature DB >> 28892130

Fibrinogen-like protein-2 causes deterioration in cardiac function in experimental autoimmune myocarditis rats through regulation of programmed death-1 and inflammatory cytokines.

Zhenzhong Zheng1,2, Yinghui Yu1,2,3, Ratnakar Potla4, Yujing Wu1,2, Hao Wu4.   

Abstract

Programmed death-1 (PD-1) plays an important role in protecting against inflammation and myocyte damage in T-cell-mediated myocarditis. To understand whether fibrinogen-like protein-2 (FGL2) can affect the role of the PD-1/PD-L1 pathway in experimental autoimmune myocarditis (EAM), we investigated cardiac function in EAM rats over-expressing FGL2. Over-expression of FGL2 significantly decreased PD-1 and deteriorated cardiac function in rats with autoimmune myocarditis. Histopathology revealed increased inflammatory cell infiltrate in EAM-FGL2 rats compared with the control groups (EAM, EAM-GFP and NC). Notably, transcription factor forkhead box P3 (Foxp3) and retinoic acid-related orphan receptor γt (RORγt) protein and mRNA levels were statistically (P < 0·05) increased in EAM rats. We also found that interferon-γ, interleukin-6, interleukin-17 and brain natriuretic peptide levels were profoundly increased in serum of FGL2 over-expressing EAM rats. Hence, FGL2 plays an important role in the pathogenesis of autoimmune myocarditis that also involves the PD-1/PD-L1 pathway. Our findings may provide novel therapeutic targets for the treatment of immune-induced heart injury.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  cardiac function; experimental autoimmune myocarditis; fibrinogen-like protein-2; inflammatory cytokines; programmed death-1

Mesh:

Substances:

Year:  2017        PMID: 28892130      PMCID: PMC5765378          DOI: 10.1111/imm.12837

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells.

Authors:  Giorgio Raimondi; William J Shufesky; Daisuke Tokita; Adrian E Morelli; Angus W Thomson
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

2.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

3.  Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.

Authors:  Yoshinori Seko; Hideo Yagita; Ko Okumura; Miyuki Azuma; Ryozo Nagai
Journal:  Cardiovasc Res       Date:  2007-03-16       Impact factor: 10.787

4.  Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.

Authors:  S Rezkalla; R A Kloner; G Khatib; R Khatib
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

5.  PD-1 protects against inflammation and myocyte damage in T cell-mediated myocarditis.

Authors:  Margarite L Tarrio; Nir Grabie; De-xiu Bu; Arlene H Sharpe; Andrew H Lichtman
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

6.  CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.

Authors:  Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

7.  Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Authors:  Julie A Lucas; Julia Menke; Whitney A Rabacal; Frederick J Schoen; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding.

Authors:  Xuemei Zhong; Joseph R Tumang; Wenda Gao; Chunyan Bai; Thomas L Rothstein
Journal:  Eur J Immunol       Date:  2007-09       Impact factor: 5.532

9.  Upregulation of Programmed Death-1 and Its Ligand in Cardiac Injury Models: Interaction with GADD153.

Authors:  Babak Baban; Jun Yao Liu; Xu Qin; Neal L Weintraub; Mahmood S Mozaffari
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  4 in total

Review 1.  PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism.

Authors:  Hao Dong; Yihang Qi; Xiangyi Kong; Zhongzhao Wang; Yi Fang; Jing Wang
Journal:  Front Pharmacol       Date:  2022-04-19       Impact factor: 5.988

2.  Surrogate Cerebrospinal Fluid Biomarkers for Assessing the Efficacy of Gene Therapy in Hurler Syndrome.

Authors:  Reiner F Haseloff; Stephanie Trudel; Ramona Birke; Michael Schümann; Eberhard Krause; Cathy Gomila; Jean-Michel Heard; Ingolf E Blasig; Jérôme Ausseil
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

3.  Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing.

Authors:  Ninaad Lasrado; Nicholas Borcherding; Rajkumar Arumugam; Timothy K Starr; Jay Reddy
Journal:  iScience       Date:  2022-02-02

4.  Altered Phenotype of Circulating Dendritic Cells and Regulatory T Cells from Patients with Acute Myocarditis.

Authors:  Paola Del Carmen Guerra-de-Blas; Daniela Cruz-González; Elena B Martínez-Shio; Roberto González-Amaro; Héctor González-Pacheco; Esther Layseca-Espinosa; Carlos D Escobedo-Uribe; Adriana E Monsiváis-Urenda
Journal:  J Immunol Res       Date:  2022-02-28       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.